434
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

Prevalence of Microalbuminuria Among Diabetes Patients in Africa: A Systematic Review and Meta-Analysis

, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2089-2103 | Received 25 Feb 2023, Accepted 03 Jul 2023, Published online: 11 Jul 2023

References

  • Shah N, Amanullah SJ, Marwat MA. Association of hyperuricemia with diabetic nephropathy in type 2 diabetes mellitus. KJMS. 2014;7(2):267.
  • Li Y, Zhao L, Yu D, Ding G. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. PLoS One. 2018;13(10):e0205709. doi:10.1371/journal.pone.0205709
  • Khan MA, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes–global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107. doi:10.2991/jegh.k.191028.001
  • Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
  • Atlas D. International diabetes federation. In: IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015:33.
  • Naicker S, Ashuntantang G. End stage renal disease in sub-Saharan Africa. Chronic Kidney Dis Disadv Popul. 2017;2017:125–137.
  • Story M, Stang J. Nutrition needs of adolescents. Guidelines Adolesc Nutr Services. 2005;3(1):21–34.
  • Obineche EN, Adem A. Update in diabetic nephropathy. Int J Diabetes Metabol. 2005;13(1):1. doi:10.1159/000497567
  • John S. Complication in diabetic nephropathy. Diabetes Metabol Synd. 2016;10(4):247–249. doi:10.1016/j.dsx.2016.06.005
  • Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
  • Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662–664. doi:10.1016/S0140-6736(19)32977-0
  • Wolf G. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest. 2004;34(12):785–796. doi:10.1111/j.1365-2362.2004.01429.x
  • Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014;18(1):1. doi:10.4196/kjpp.2014.18.1.1
  • Yadav B, Shashidhar KN, Raveesha A, Muninarayana C. Assessment of cystatin C and microalbumin as biomarkers for nephropathy in patients with type 2 diabetes mellitus. J Evol Med Dent Sci. 2022;10(25):1866–1871. doi:10.14260/jemds/2021/386
  • Pecoits-Filho R, Abensur H, Betônico CC, et al. Interactions between kidney disease and diabetes: dangerous liaisons. Diabetol Metab Syndr. 2016;8(1):1–21. doi:10.1186/s13098-016-0159-z
  • American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33(Supplement_1):S11–61. doi:10.2337/dc10-S011
  • Dronavalli S, Duka I, Bakris GL. The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab. 2008;4(8):444–452. doi:10.1038/ncpendmet0894
  • Warram JH, Scott LJ, Hanna LS, et al. Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes. 2000;49(1):94–100. doi:10.2337/diabetes.49.1.94
  • De Boer IH, Rue TC, Cleary PA, et al.; Diabetes Control and Complications Trial, Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med. 2011;171(5):412–420. doi:10.1001/archinternmed.2011.16
  • Hovind P, Tarnow L, Rossing P, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ. 2004;328(7448):1105. doi:10.1136/bmj.38070.450891.FE
  • Ammirati AL. Chronic kidney disease. Revista da Associação Médica Brasileira. 2020;66:s03–9. doi:10.1590/1806-9282.66.S1.3
  • Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. Diabetologia. 1989;32(4):219–226. doi:10.1007/BF00285287
  • Ho YW, Chau KF, Leung CB, et al. Hong Kong registry report 2004. Hong Kong J Nephrol. 2005;7(1):38–46. doi:10.1016/S1561-5413(09)60179-4
  • Jerums G, Maclsaac RJ. Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol. 2002;1(3):163–173. doi:10.2165/00024677-200201030-00004
  • Dadhania BP, Aravat AH, Dhruva GA. Study of microalbuminuria in diabetes type 2 patients as a marker of morbidity (a study of 100 cases in Rajkot city). Int J Biomed Adv Res. 2012;3(10):763–766. doi:10.7439/ijbar.v3i10.769
  • Chen C, Wang C, Hu C, et al. Normoalbuminuric diabetic kidney disease. Front Med. 2017;11(3):310–318. doi:10.1007/s11684-017-0542-7
  • Goud MB, Devi SO, Nayal B, Begum S. Bio-chemical aspects, pathophysiology of microalbuminuria and glycated hemoglobin in type 2 diabetes mellitus. In: Pathophysiology and Complications of Diabetes Mellitus. IntechOpen; 2012.
  • Roscioni SS, Heerspink HJ, De Zeeuw D. Microalbuminuria: target for renoprotective therapy PRO. Kidney Int. 2014;86(1):40–49. doi:10.1038/ki.2013.490
  • Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: the continuing saga. Diabetes Care. 2014;37(3):867–875. doi:10.2337/dc13-1870
  • Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes. 1990;39(9):1116–1124. doi:10.2337/diab.39.9.1116
  • Zelmanovitz T, Gerchman F, Balthazar AP, Thomazelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndr. 2009;1:10. doi:10.1186/1758-5996-1-10
  • Ogundele SB. Chronic kidney disease in sub-Saharan Africa. Saudi J Kidney Dis Transpl. 2018;29(5):1188. doi:10.4103/1319-2442.243945
  • Moher D, Liberati A, Tetzlaff J, Altman DG; Prisma Group. Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther. 2009;89(9):873–880. doi:10.1093/ptj/89.9.873
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557
  • Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed‐effect and random‐effects models for meta‐analysis. Res Synthesis Methods. 2010;1(2):97–111. doi:10.1002/jrsm.12
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. doi:10.2307/2533446
  • Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–1160. doi:10.1093/ije/dyn204
  • Rasmussen JB, Thomsen JA, Rossing P, Parkinson S, Christensen DL, Bygbjerg IC. Diabetes mellitus, hypertension and albuminuria in rural Z ambia: a hospital‐based survey. Trop Med Int Health. 2013;18(9):1080–1084. doi:10.1111/tmi.12139
  • Rahlenbeck SI, Gebre-Yohannes A. Prevalence and epidemiology of micro-and macroalbuminuria in Ethiopian diabetic patients. J Diabetes Complications. 1997;11(6):343–349. doi:10.1016/S1056-8727(96)00122-5
  • Muse AI, Osman MO, Wedajo GT, et al. Prevalence of microalbuminuria and associated factors among type 2 diabetes mellitus patients in Jigjiga Town Public Hospitals, Somali Regional State, Ethiopia. Res Square. 2020. doi:10.21203/rs.3.rs-936394/v1
  • Ogiator M, Ojobi J, Ijachi O, Asor P. Association between microalbuminuria and hypertension among type 2 diabetes mellitus patients attending Benue State University Teaching Hospital, Makurdi, North Central, Nigeria. Int J Med Rev Case Rep. 2020;4(5):24.
  • Ufuoma C, Ngozi JC, Kester AD, Godwin YD. Prevalence and risk factors of microalbuminuria among type 2 diabetes mellitus: a hospital-based study from, Warri, Nigeria. Sahel Med J. 2016;19(1):16. doi:10.4103/1118-8561.181889
  • Halliru HA, Musa B, Dahiru SD, Koki YA, Adamu S, Adamu SM. Microalbuminuria as an index of diabetic nephropathy among chronic diabetic patients in Gumel, North Western Nigeria. J Diabetol. 2016;7(3):155.
  • Erasmus RT, Oyeyinka G, Arije A. Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy. Postgrad Med J. 1992;68(802):638–642. doi:10.1136/pgmj.68.802.638
  • Bissong ME, Teke GN, Sanje M, Goneh H, Foka FE, Kamga HL. Microalbuminuria in diabetic patients in the Bamenda health district. Sci J Clin Med. 2017;6(4):63–67. doi:10.11648/j.sjcm.20170604.14
  • Efundem NT, Assob JC, Feteh VF, Choukem SP. Prevalence and associations of microalbuminuria in proteinuria-negative patients with type 2 diabetes in two regional hospitals in Cameroon: a cross-sectional study. BMC Res Notes. 2017;10(1):1–5. doi:10.1186/s13104-017-2804-5
  • Rahamtalla FA, Elagib AA, Mahdi A, Ahmed SM. Prevalence of microalbuminuria among sudanese type 2 diabetic patients at elmusbah center at ombadda—omdurman. IOSR J Pharm. 2012;2(5):51–55.
  • Lutale JJ, Thordarson H, Abbas ZG, Vetvik K. Microalbuminuria among type 1 and type 2 diabetic patients of African origin in Dar es Salaam, Tanzania. BMC Nephrol. 2007;8(1):1–8. doi:10.1186/1471-2369-8-2
  • Ghosh S, Lyaruu I, Yeates K. Prevalence and factors associated with microalbuminuria in type 2 diabetic patients at a diabetes clinic in northern Tanzania. Afri J Diabetes Med. 2012;20(2):247.
  • Kantarama E, Uwizeye D, Mselle T. Prevalence and correlates of microalbuminuria among type 2 diabetes patients at Muhimbili National Hospital, Dar es Salaam, Tanzania. Rwanda J Med Health Sci. 2021;4(1):84–97. doi:10.4314/rjmhs.v4i1.7
  • Martin M, Edrisa M, SSinabulya I, Samuel K, Frank M, Kiiza MC. Microalbuminuria among newly diagnosed diabetic patients at mulago national referral hospital in Uganda: a cross sectional study. J Obes Weight Loss Med. 2018;4(1). doi:10.23937/2572-4010.1510021
  • Kiconco R, Rugera SP, Kiwanuka GN. Microalbuminuria and traditional serum biomarkers of nephropathy among diabetic patients at Mbarara regional referral hospital in south western Uganda. J Diabetes Res. 2019;2019:1–7. doi:10.1155/2019/3534260
  • Lubwama SK. Prevalence and factors associated with microalbuminuria in children and adolescents with Type 1 Diabetes in Mulago and Nsambya Hospitals in Uganda (Doctoral dissertation); Makerere University; 2022. Available from: http://hdl.handle.net/10570/10104.
  • Kalk WJ, Raal FJ, Joffe BI. The prevalence and incidence of and risk factors for, micro-albuminuria among urban Africans with type 1 diabetes in South Africa: an inter-ethnic study. Int J Diabetes Mellit. 2010;2(3):148–153. doi:10.1016/j.ijdm.2010.10.003
  • Molefe-Baikai OJ, Molefi M, Cainelli F, Rwegerera GM. The prevalence of microalbuminuria and associated factors among patients with type 2 diabetes mellitus in Botswana. Niger J Clin Pract. 2018;21(11):1430–1437. doi:10.4103/njcp.njcp_224_18
  • Ramaphane T, Gezmu AM, Tefera E, et al. Prevalence and factors associated with microalbuminuria in pediatric patients with type 1 diabetes mellitus at a large tertiary-level hospital in Botswana. Diabetes Metabol Syndr Obes. 2021;14:4415. doi:10.2147/DMSO.S322847
  • Fetni S, Goudjil T, Zekri S, Lemdaoui MC. the diagnosis of diabetic kidney disease; frequencies of urinary microalbumin and creatinine ratios, and the establishment of causal relationships between lipid and glycemic levels and obesity in an Algerian population. Acta Medica. 2021;37:2433. doi:10.19193/0393-6384_2021_5_377
  • Eghan BA, Frempong MT, Adjei-Poku M. Prevalence and predictors of microalbuminuria in patients with diabetes mellitus: a cross-sectional observational study in Kumasi, Ghana. Ethn Dis. 2007;17(4):726.
  • Amolo PA. The prevalence of microalbuminuria in children and adolescents with type 1 Diabetes mellitus at the outpatient clinic in Kenyatta National Hospital (Doctoral dissertation), University of Nairobi; 2021. Available from: http://erepository.uonbi.ac.ke:8080/xmlui/handle/11295/25090.
  • Omar MA, Rezk MM, El-Kafoury AA, Kandil MS. Microalbuminuria and glycated hemoglobin in children with type 1 diabetes mellitus. Alexandria J Med. 2015;51(1):83–88. doi:10.1016/j.ajme.2014.04.005
  • Djiby S, Demba D, Assane NM, et al. Prevalence of microalbuminury and associated risk factors in a population of diabetics followed at the Marc Sankale Center of Dakar. Open J Internal Med. 2018;8(1):24–32. doi:10.4236/ojim.2018.81004
  • Chaamba SG. Microalbuminuria and serum creatinine in type 2 diabetes mellitus patients attending renal clinic at university teaching hospital in Lusaka, Zambia (Doctoral dissertation). The University of Zambia; 2019. Available from: http://dspace.unza.zm/handle/123456789/6184.
  • Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44(3):191–196. doi:10.1016/S0168-8227(99)00052-2
  • Mohamed AA. Prevalence of Microalbuminuria & Retinopathy among adolescents with Insulin Dependent Diabetes Mellitus (IDDM) (Doctoral dissertation). University of Khartoum; 2005.
  • Bunza FU, Mainasara AS, Dallatu MK, Bunza JM, Wasagu IZ. Prevalence of microalbuminuria among diabetic patients in Usmanu Danfodiyo University Teaching Hospital, Sokoto. Bayero J Pure Appl Sci. 2014;7(1):1–5. doi:10.4314/bajopas.v7i1.1
  • Yarhere IE, Jaja T, Anolue M. Microalbuminuria in type 1 diabetes mellitus children in University of Port Harcourt Teaching Hospital, Nigeria. Pan Afri Med J. 2020;36(1). doi:10.11604/pamj.2020.36.161.23782
  • Raji L. Recommendations for the management of special populations, renal disease in diabetes. Am J Hypertens. 2003;16:46–49. doi:10.1016/j.amjhyper.2003.07.006
  • Weir MR. Microalbuminuria in type 2 diabetes: an important overlooked cardiovascular risk factor. J Clin Hypertens. 2004;6:134–143. doi:10.1111/j.1524-6175.2004.02524.x
  • Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69(11):2057–2063. doi:10.1038/sj.ki.5000377
  • Shin JI, Chang AR, Grams ME, et al. Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium. Hypertension. 2021;78(4):1042–1052. doi:10.1161/HYPERTENSIONAHA.121.17323
  • Ahmedani MY, Hydrie MZ, Iqbal A, Gul A, Mirza WB, Basit A. Prevalence of microalbuminuria in type 2 diabetic patients in Karachi: Pakistan a multi-center study. Hypertension. 2005;2194:99–107.
  • Pasko N, Toti F, Strakosha A, et al. Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy. Hippokratia. 2013;17(4):337.
  • Alzaid AA, Sobki S, De Silva V. Prevalence of microalbuminuria in Saudi Arabians with non-insulin-dependent diabetes mellitus: a clinic-based study. Diabetes Res Clin Pract. 1994;26(2):115–120. doi:10.1016/0168-8227(94)90148-1
  • Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview 17 of the literature. Arch Intern Med. 1997;157(13):1413–1418. doi:10.1001/archinte.1997.00440340025002
  • Gall MA, Rossing P, Skøtt P, et al. Prevalence of micro-and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1991;34(9):655–661. doi:10.1007/BF00400995
  • Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab kidney study. Kidney Int. 2004;66:S22–4. doi:10.1111/j.1523-1755.2004.09206.x
  • Kanakamani J, Ammini AC, Gupta N, Dwivedi SN. Prevalence of microalbuminuria among patients with type 2 diabetes mellitus—a hospital-based study from north India. Diabetes Technol Ther. 2010;12(2):161–166. doi:10.1089/dia.2009.0133
  • Afkhami-Ardekani M, Modarresi M, Amirchaghmaghi E. Prevalence of microalbuminuria and its risk factors in type 2 diabetic patients. Indian J Nephrol. 2008;18(3):112. doi:10.4103/0971-4065.43690
  • Klein R, Klein BE, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care. 1993;16(10):1325–1330. doi:10.2337/diacare.16.10.1325
  • Parving HH, Persson F, Rossing P. Microalbuminuria: a parameter that has changed diabetes care. Diabetes Res Clin Pract. 2015;107(1):1–8. doi:10.1016/j.diabres.2014.10.014
  • Al-Maskari F, El-Sadig M, Obineche E. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. BMC Nephrol. 2008;9(1):1–8. doi:10.1186/1471-2369-9-1
  • Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type 1 diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996;7:930–937. doi:10.1681/ASN.V76930
  • Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–176. doi:10.2337/diacare.28.1.164
  • Dabla PK. Renal function in diabetic nephropathy. World J Diabetes. 2010;1(2):48–56. doi:10.4239/wjd.v1.i2.48
  • Toyama T, Furuichi K, Ninomiya T, et al. The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis. PLoS One. 2013;8(8):e71810. doi:10.1371/journal.pone.0071810
  • Adebisi SA, Okesina AB, Abu EO. Microalbuminuria in type 2 diabetic patients in ilorin, Nigeria. 2001.
  • Chowta NK, Pant P, Chowta MN. Microalbuminuria in diabetes mellitus: association with age, sex, weight, and creatinine clearance. Indian J Nephrol. 2009;19(2):53. doi:10.4103/0971-4065.53322